Samuel Davenport

Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, PC

$ $$$

Boston 02110 MA US

Samuel F. Davenport is a trial lawyer who specializes in litigation related to the development and commercialization of drugs, biologics, diagnostics devices, and medical devices, including disputes over licensing, royalties, and the research and development process.

Sam also regularly litigates business disputes for clean technology, information technology, real estate, and waste industry companies. Advising senior executives and boards on how their companies can avoid litigation is another significant part of his practice.

A trial lawyer in the firm’s Boston office, Sam has extensive experience representing a wide variety of clients in complex business litigation before courts and arbitration panels across the country.

In particular, Sam specializes in representing life sciences companies in litigation over licensing, royalties, research, development, and commercialization, and counseling their senior executives and boards about how to pursue development/commercialization strategies in ways that will preserve their company’s rights and minimize the risk of litigation.

Sam also regularly represents companies in the clean technology, IT, real estate, and waste industries in disputes over strategic alliances, joint ventures, profit sharing agreements, licensing, financing, and vendor agreements. Sam is an active member of the firm’s Life Sciences Working Group and Alternative Dispute Resolution Working Group.

In 2002, while on leave from the firm, Sam served as a special assistant district attorney in the Middlesex County District Attorney’s Office, where he prosecuted over 100 criminal matters and tried more than a dozen cases. While in law school, Sam served as a legal intern for the Honorable William G. Young of the U.S. District Court for the District of Massachusetts.

EXPERIENCE :

  • Advised a publicly owned biotechnology company in the successful resolution of a dispute with its collaboration partner over the development of cardiac-related therapies, as well as the successful termination of the parties’ collaboration agreement.
  • Represented an Arizona county in the successful resolution of a dispute with a waste hauling company over the parties’ rights under a long-term hauling and disposal agreement with California municipal landfill.
  • Represented a privately owned solar project development company in the successful settlement of a dispute over a solar power purchase agreement.
  • Advised a privately owned European diagnostics company in the successful resolution of a dispute with a Fortune 100 pharmaceutical company over royalty payments related to the parties’ jointly-developed diagnostic product.
  • Advised a privately owned pharmaceutical company with respect to several disputes with its collaboration partner, a Fortune 100 pharmaceutical company, over milestone payments and the development of novel therapies for the treatment of drug resistant infections.
  • Represented Taiwanese creditor in complex civil RICO case in California federal court involving claims against 34 foreign and domestic defendants. The firm achieved a successful settlement of the case at the commencement of trial.
  • Represented a privately owned New York real estate development company in the prosecution and successful settlement of an arbitration against a South Carolina real estate development company over an agreement governing the client’s first-of-its-kind development of LEED certified homes.
  • Represented a Fortune 500 biotechnology company in an arbitration brought against it by a Fortune 100 pharmaceutical company to gain control over the right to commercialize a novel, billion-dollar multiple sclerosis drug. Following a multi-week hearing, the arbitrator ruled in favor of the client on all claims.
  • Represented a publicly owned in vitro diagnostic manufacturer in the successful settlement of an arbitration involving claims that the client’s licensee and exclusive distributor had failed to develop and commercialize the manufacturer’s MicroRNA-based products in the oncology market.

INVOLVEMENT :

  • Past Trial Advisor, Harvard Law School Trial Advocacy Workshop
  • Member, American Bar Association
  • Member, Massachusetts Bar Association
  • Trustee, Manomet Center for Conservation Sciences
  • Committee Member (and former Chair), Duxbury Bay Management Committee

EDUCATION :

  • Northeastern University (JD)
  • Connecticut College (BA)

ADMISSIONS : Massachusetts

Cost

Rate : $$$$

Contact for details

Rate and write a review

Your email address will not be published. Required fields are marked *

Is this your profile?Claim it now.

Make sure your information is up to date.
Boston 02110 MA US
Get directions

Lina Stillman

5.0
Broadway 42
New York 10006 NY US
Advertisement